Impact of adverse effects of bevacizumab on survival outcomes of patients with recurrent glioblastoma.
Mohamed Ali Hamza
No relevant relationships to disclose
Carlos Kamiya Matsuoka
No relevant relationships to disclose
John Frederick De Groot
Consultant or Advisory Role - Roche/Genentech